about
Phosphorothioate oligonucleotide quantification by μ-liquid chromatography-mass spectrometry.Mass spectrometry of modified RNAs: recent developmentsLC-MS of oligonucleotides: applications in biomedical research.Advances in quantitative bioanalysis of oligonucleotide biomarkers and therapeutics.Pharmacokinetics and Pharmacodynamics of a 13-mer LNA-inhibitor-miR-221 in Mice and Non-human Primates.Systematic optimization of ion-pairing agents and hexafluoroisopropanol for enhanced electrospray ionization mass spectrometry of oligonucleotides.Desulfurization of phosphorothioate oligonucleotides via the sulfur-by-oxygen replacement induced by the hydroxyl radical during negative electrospray ionization mass spectrometry.Characterization of Byproducts from Chemical Syntheses of Oligonucleotides Containing 1-Methyladenine and 3-Methylcytosine.Quantitative analysis of imetelstat in plasma with LC-MS/MS using solid-phase or hybridization extraction.Quantification of oligonucleotides by LC-MS/MS: the challenges of quantifying a phosphorothioate oligonucleotide and multiple metabolites.Preliminary investigation into the use of a real-time PCR method for the quantification of an oligonucleotide in human plasma and the development of novel acceptance criteria.Regulated bioanalysis of oligonucleotide therapeutics and biomarkers: qPCR versus chromatographic assays.Quantitative determination of a siRNA (AD00370) in rat plasma using peptide nucleic acid probe and HPLC with fluorescence detection.
P2860
Q36331548-6B1786A6-3CBE-4C0F-8AD4-61E049D14D15Q36372687-4F8007AD-7A26-4338-BF4D-B3157B25933DQ38232125-68DB7FDB-2B3F-4BF3-85E9-BB2B95D7122FQ38664738-DC9BE1E1-315B-4DC6-9641-D142DEFA2630Q39667223-E0B65E86-6744-48DA-8499-4BC36DA7CC30Q43858618-9C419447-7597-4E23-8E97-48EE338E4901Q44365925-C1D1322F-175B-48CE-890D-A8D73160F45DQ47160383-FCE556B6-D062-433E-9FBB-D2F68452CDE6Q50075192-55CB7F8B-C2F7-46AA-B8F8-7A33D67EE7A9Q51751634-73C9F901-9142-4023-97DB-30D73D2BF74EQ54227861-75A8486E-4927-4714-B532-2DA129DC64B8Q54235059-ED8919CB-40A6-4432-BDAB-D3F164E284D7Q54477220-9230D8A7-2750-4141-A8D9-CA7877EA2D67
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Bioanalytical LC-MS of therapeutic oligonucleotides.
@en
Bioanalytical LC-MS of therapeutic oligonucleotides.
@nl
type
label
Bioanalytical LC-MS of therapeutic oligonucleotides.
@en
Bioanalytical LC-MS of therapeutic oligonucleotides.
@nl
prefLabel
Bioanalytical LC-MS of therapeutic oligonucleotides.
@en
Bioanalytical LC-MS of therapeutic oligonucleotides.
@nl
P2860
P356
P1433
P1476
Bioanalytical LC-MS of therapeutic oligonucleotides.
@en
P2093
William D van Dongen
P2860
P304
P356
10.4155/BIO.11.8
P577
2011-03-01T00:00:00Z